Genome & Company Market Cap

Genome & Company has a market cap or net worth of 163.51 billion as of December 5, 2025. Its market cap has increased by 48.72% in one year.

Market Cap

163.51B

Enterprise Value

152.64B

Revenue

25.95B

Ranking

n/a

PE Ratio

n/a

Stock Price

5,260.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 163.51B, an increase of 127.48%. That is a compound annual growth rate of 12.56%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	163.51B	91.90%
Dec 30, 2024	85.21B	-51.64%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	1,048.46B	224.28%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Electronics	709.49T
SK hynix	375.61T
LG Energy Solution	99.68T
Samsung Biologics	75.96T
Hyundai Motor Company	68.19T
Doosan Enerbility	51.49T
Kia Corporation	47.79T
HD Hyundai Heavy Industries	47.40T

Market Cap Rankings